Gilead to Test Inhaled Form of Anti-Covid Drug to Widen Its Use

(Bloomberg) -- Gilead Sciences Inc. said it plans to start human trials of an inhaled version of its anti-Covid-19 drug remdesivir, a move that could significantly expand its use if successful.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.